Diabetes mellitus and sudden cardiac death: What are the data?

Cardiology Journal

Volumn 17, Issue 2, 2010, Pages 117-129

  Bergner, Daniel W ^a   Goldberger, Jeffrey J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Autonomic; Diabetes mellitus; Sudden cardiac death

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; POTASSIUM;

AUTONOMIC DYSFUNCTION; CARDIAC AUTONOMIC NEUROPATHY; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; GLYCEMIC CONTROL; HEART REPOLARIZATION; HUMAN; HYPERCAPNIA; HYPERCHOLESTEROLEMIA; HYPERCOAGULABILITY; HYPERTENSION; HYPOGLYCEMIA; HYPOXIA; INSULIN DEPENDENT DIABETES MELLITUS; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; QT PROLONGATION; REVIEW; RISK ASSESSMENT; SILENT MYOCARDIAL ISCHEMIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUDDEN DEATH; ADULT; AGED; COMORBIDITY; DEATH, SUDDEN, CARDIAC; DIABETES COMPLICATIONS; EVIDENCE BASED MEDICINE; FEMALE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; REPRODUCIBILITY; RISK FACTOR;

ADULT; AGED; COMORBIDITY; DEATH, SUDDEN, CARDIAC; DIABETES COMPLICATIONS; DIABETES MELLITUS; EPIDEMIOLOGIC RESEARCH DESIGN; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS;

EID: 77951148806     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (114)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care, 2004; 27: 1047-1053.
2. Jouven X, Desnos M, Guerot C, Ducimetiere P. Predicting sudden death in the population: The Paris Prospective Study I. Circulation, 1999; 99: 1978-1983.
3. Balkau B, Jouven X, Ducimetiere P, Eschwege E. Diabetes as a risk factor for sudden death. Lancet, 1999; 354: 1968-1969.
4. Albert CM, Chae CU, Grodstein F et al. Prospective study of sudden cardiac death among women in the United States. Circulation, 2003; 107: 2096-2101.
5. Curb JD, Rodriguez BL, Burchfiel CM, Abbott RD, Chiu D, Yano K. Sudden death, impaired glucose tolerance, and diabetes in Japanese American men. Circulation, 1995; 91: 2591-2595.
6. Jouven X, Lemaitre RN, Rea TD, Sotoodehnia N, Empana JP, Siscovick DS. Diabetes, glucose level, and risk of sudden cardiac death. Eur Heart J, 2005; 26: 2142-2147.
7. Kannel WB, Wilson PW, D'Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J, 1998; 136: 205-212.
8. Escobedo LG, Caspersen CJ. Risk factors for sudden coronary death in the United States. Epidemiology, 1997; 8: 175-180.
9. Sexton PT, Walsh J, Jamrozik K, Parsons R. Risk factors for sudden unexpected cardiac death in Tasmanian men. Aust NZJ Med, 1997; 27: 45-50.
10. Fox CS, Evans JC, Larson MG, Kannel WB, Levy D. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: The Framingham Heart Study. Circulation, 2004; 110: 522-527.
11. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation, 2001; 104: 2158-2163.
12. Roberts WC. Sudden cardiac death: definitions and causes. Am J Cardiol, 1986; 57: 1410-1413.
13. Kuller L, Lilienfeld A, Fisher R. An epidemiological study of sudden and unexpected deaths in adults. Medicine (Baltimore), 1967; 46: 341-361.
14. Chugh SS, Jui J, Gunson K et al. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol, 2004; 44: 1268-1275.
15. Wannamethee G, Shaper AG, Macfarlane PW, Walker M. Risk factors for sudden cardiac death in middle-aged British men. Circulation, 1995; 91: 1749-1756.
16. Suhonen O, Reunanen A, Knekt P, Aromaa A. Risk factors for sudden and non-sudden coronary death. Acta Med Scand, 1988; 223: 19-25.
17. Hinkle LE, Jr., Thaler HT. Clinical classification of cardiac deaths. Circulation, 1982; 65: 457-464.
18. Simon SR, Powell LH, Bartzokis TC, Hoch DH. A new system for classification of cardiac death as arrhythmic, ischemic, or due to myocardial pump failure. Am J Cardiol, 1995; 76: 896-898.
19. Farb A, Tang AL, Burke AP, Sessums L, Liang Y, Virmani R. Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. Circulation, 1995; 92: 1701-1709.
20. Liberthson RR, Nagel EL, Hirschman JC, Nussenfeld SR, Blackbourne BD, Davis JH. Pathophysiologic observations in prehospital ventricular fibrillation and sudden cardiac death. Circulation, 1974; 49: 790-798.
21. Warnes CA, Roberts WC. Sudden coronary death: relation of amount and distribution of coronary narrowing at necropsy to previous symptoms of myocardial ischemia, left ventricular scarring and heart weight. Am J Cardiol, 1984; 54: 65-73.
22. Wackers FJ, Young LH, Inzucchi SE et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: The DIAD study. Diabetes Care, 2004; 27: 1954-1961.
23. Zellweger MJ, Hachamovitch R, Kang X et al. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J, 2004; 25: 543-550.
24. Rajagopalan N, Miller TD, Hodge DO, Frye RL, Gibbons RJ. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol, 2005; 45: 43-49.
25. Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group. Am J Cardiol, 1997; 79: 134-139.
26. Bax JJ, Bonow RO, Tschope D, Inzucchi SE, Barrett E. The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes. J Am Coll Cardiol, 2006; 48: 754-760.
27. Gazzaruso C, Garzaniti A, Giordanetti S et al. Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: A role for lipoprotein(a) and apolipoprotein(a) polymorphism. Diabetes Care, 2002; 25: 1418-1424.
28. Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V. Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care, 1999; 22: 1396-1400.
29. Fleg JL, Gerstenblith G, Zonderman AB. Prevalence and prognostic significance of exercise-induced silent myocardial ischemia detected by thallium scintigraphy and electrocardiography in asymptomatic volunteers. Circulation, 1990; 81: 428-436.
30. Koistinen MJ. Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. BMJ, 1990; 301: 92-95.
31. Sorajja P, Chareonthaitawee P, Rajagopalan N. Improved survival in asymptomatic diabetic patients with high-risk SPECT imaging treated with coronary artery bypass grafting. Circulation, 2005; 112: I311-316.
32. Miyazaki T, Zipes DP. Pericardial prostaglandin biosynthesis prevents the increased incidence of reperfusion-induced ventricular fibrillation produced by efferent sympathetic stimulation in dogs. Circulation, 1990; 82: 1008-1019.
33. Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS, Jr., Foreman RD, Schwartz PJ. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res, 1991; 68: 1471-1481.
34. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care, 1985; 8: 491-498.
35. Neil HA, Thompson AV, John S, McCarthy ST, Mann JI. Diabetic autonomic neuropathy: The prevalence of impaired heart rate variability in a geographically defined population. Diabet Med, 1989; 6: 20-24.
36. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care, 2003; 26: 1553-1579.
37. Ziegler D, Gries FA, Spuler M, Lessmann F. The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group. J Diabetes Compl, 1992; 6: 49-57.
38. O'Brien IA, O'Hare JP, Lewin IG, Corrall RJ. The prevalence of autonomic neuropathy in insulin-dependent diabetes mellitus: A controlled study based on heart rate variability. QJ Med, 1986; 61: 957-967.
39. Javorka M, Javorkova J, Tonhajzerova I, Javorka K. Parasympathetic versus sympathetic control of the cardiovascular system in young patients with type 1 diabetes mellitus. Clin Physiol Funct Imaging, 2005; 25: 270-274.
40. Karamitsos DT, Didangelos TP, Athyros VG, Kontopoulos AG. The natural history of recently diagnosed autonomic neuropathy over a period of 2 years. Diabetes Res Clin Pract, 1998; 42: 55-63.
41. Ewing DJ. Diabetic autonomic neuropathy and the heart. Diabetes Res Clin Pract Suppl, 1996; 30: 31-36.
42. Schnell O, Hammer K, Muhr-Becker D. Cardiac sympathetic dysinnervation in type 2 diabetes mellitus with and without ECG-based cardiac autonomic neuropathy. J Diabetes Compl, 2002; 16: 220-227.
43. Orchard TJ, Lloyd CE, Maser RE, Kuller LH. Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Res Clin Pract Suppl, 1996; 34: S165-S171.
44. Stella P, Ellis D, Maser RE, Orchard TJ. Cardiovascular autonomic neuropathy (expiration and inspiration ratio) in type 1 diabetes. Incidence and predictors. J Diabetes Comp, 2000; 14: 1-6.
45. Valensi P, Huard JP, Giroux C, Attali JR. Factors involved in cardiac autonomic neuropathy in diabetic patients. J Diabetes Compl, 1997; 11: 180-187.
46. Valensi P, Paries J, Attali JR. Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications: The French multicenter study. Metabolism, 2003; 52: 815-820.
47. Witte DR, Tesfaye S, Chaturvedi N, Eaton SE, Kempler P, Fuller JH. Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia, 2005; 48: 164-171.
48. Chen HS, Hwu CM, Kuo BI et al. Abnormal cardiovascular reflex tests are predictors of mortality in type 2 diabetes mellitus. Diabet Med, 2001; 18: 268-273.
49. Hathaway DK, el-Gebely S, Cardoso SS, Elmer DS, Gaber AO. Autonomic cardiac dysfunction in diabetic transplant recipients succumbing to sudden cardiac death. Transplantation, 1995; 59: 634-637.
50. Lee KH, Jang HJ, Kim YH et al. Prognostic value of cardiac autonomic neuropathy independent and incremental to perfusion defects in patients with diabetes and suspected coronary artery disease. Am J Cardiol, 2003; 92: 1458-1461.
51. Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: A meta-analysis. Diabetes Care, 2003; 26: 1895-1901.
52. Nagamachi S, Fujita S, Nishii R et al. Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non-insulin-dependent diabetes mellitus. J Nucl Cardiol, 2006; 13: 34-42.
53. Navarro X, Kennedy WR, Aeppli D, Sutherland DE. Neuropathy and mortality in diabetes: influence of pancreas transplantation. Muscle Nerve, 1996; 19: 1009-1016.
54. Rathmann W, Ziegler D, Jahnke M, Haastert B, Gries FA. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med, 1993; 10: 820-824.
55. Sawicki PT, Dahne R, Bender R, Berger M. Prolonged QT interval as a predictor of mortality in diabetic nephropathy. Diabetologia, 1996; 39: 77-81.
56. Valensi P, Sachs RN, Harfouche B et al. Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care, 2001; 24: 339-343.
57. Veglio M, Sivieri R, Chinaglia A, Scaglione L, Cavallo-Perin P. QT interval prolongation and mortality in type 1 diabetic patients: A 5-year cohort prospective study. Neuropathy Study Group of the Italian Society of the Study of Diabetes, Piemonte Affiliate. Diabetes Care, 2000; 23: 1381-1383.
58. Wheeler SG, Ahroni JH, Boyko EJ. Prospective study of autonomic neuropathy as a predictor of mortality in patients with diabetes. Diabetes Res Clin Pract, 2002; 58: 131-138.
59. Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. QJ Med, 1980; 49: 95-108.
60. Gerritsen J, Dekker JM, TenVoorde BJ et al. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: The Hoorn Study. Diabetes Care, 2001; 24: 1793-1798.
61. O'Brien IA, McFadden JP, Corrall RJ. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. QJ Med, 1991; 79: 495-502.
62. Hume L, Oakley GD, Boulton AJ, Hardisty C, Ward JD. Asymptomatic myocardial ischemia in diabetes and its relationship to diabetic neuropathy: An exercise electrocardiography study in middle-aged diabetic men. Diabetes Care, 1986; 9: 384-388.
63. Fava S, Azzopardi J, Muscat HA, Fenech FF. Factors that influence outcome in diabetic subjects with myocardial infarction. Diabetes Care, 1993; 16: 1615-1618.
64. Katz A, Liberty IF, Porath A, Ovsyshcher I, Prystowsky EN. A simple bedside test of 1-minute heart rate variability during deep breathing as a prognostic index after myocardial infarction. Am Heart J, 1999; 138: 32-38.
65. Ewing DJ, Boland O, Neilson JM, Cho CG, Clarke BF. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia, 1991; 34: 182-185.
66. Suarez GA, Clark VM, Norell JE et al. Sudden cardiac death in diabetes mellitus: risk factors in the Rochester diabetic neuropathy study. J Neurol Neurosurg Psychiatry, 2005; 76: 240-245.
67. Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J. QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation, 1991; 83: 1888-1894.
68. Dekker JM, Schouten EG, Klootwijk P, Pool J, Kromhout D. Association between QT interval and coronary heart disease in middle-aged and elderly men. The Zutphen Study. Circulation, 1994; 90: 779-785.
69. Montanez A, Ruskin JN, Hebert PR, Lamas GA, Hennekens CH. Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: A review and qualitative overview of the prospective cohort studies. Arch Intern Med, 2004; 164: 943-948.
70. Straus SM, Kors JA, De Bruin ML et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol, 2006; 47: 362-367.
71. Sivieri R, Veglio M, Chinaglia A, Scaglione P, Cavallo-Perin P. Prevalence of QT prolongation in a type 1 diabetic population and its association with autonomic neuropathy. The Neuropathy Study Group of the Italian Society for the Study of Diabetes. Diabet Med, 1993; 10: 920-924.
72. Brown DW, Giles WH, Greenlund KJ, Valdez R, Croft JB. Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QTc duration. Results from the Third National Health and Nutrition Examination Survey. J Cardiovasc Risk, 2001; 8: 227-233.
73. Suys BE, Huybrechts SJ, De Wolf D et al. QTc interval prolongation and QTc dispersion in children and adolescents with type 1 diabetes. J Pediatr, 2002; 141: 59-63.
74. Veglio M, Bruno G, Borra M. Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: A population-based cohort. J Intern Med, 2002; 251: 317-324.
75. Naas AA, Davidson NC, Thompson C et al. QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: Cohort study. BMJ, 1998; 316: 745-746.
76. Rossing P, Breum L, Major-Pedersen A et al. Prolonged QTc interval predicts mortality in patients with type 1 diabetes mellitus. Diabet Med, 2001; 18: 199-205.
77. Sawicki PT, Kiwitt S, Bender R, Berger M. The value of QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus. J Intern Med, 1998; 243: 49-56.
78. Ziegler D, Zentai CP, Perz S et al. Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: The MONICA/KORA Augsburg Cohort Study. Diabetes Care, 2008; 31: 556-561.
79. Stettler C, Bearth A, Allemann S et al. QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: A 23-year follow-up. Diabetologia, 2007; 50: 186-194.
80. Whitsel EA, Boyko EJ, Rautaharju PM et al. Electrocardiographic QT interval prolongation and risk of primary cardiac arrest in diabetic patients. Diabetes Care, 2005; 28: 2045-2047.
81. Okin PM, Devereux RB, Lee ET, Galloway JM, Howard BV. Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes: The strong heart study. Diabetes, 2004; 53: 434-440.
82. Pappachan JM, Sebastian J, Bino BC et al. Cardiac autonomic neuropathy in diabetes mellitus: Prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis. Postgrad Med J, 2008; 84: 205-210.
83. Kahn JK, Sisson JC, Vinik AI. QT interval prolongation and sudden cardiac death in diabetic autonomic neuropathy. J Clin Endocrinol Metab, 1987; 64: 751-754.
84. Kahn JK, Sisson JC, Vinik AI. Prediction of sudden cardiac death in diabetic autonomic neuropathy. J Nucl Med, 1988; 29: 1605-1606.
85. Langen KJ, Ziegler D, Weise F et al. Evaluation of QT interval length, QT dispersion and myocardial m-iodobenzylguanidine uptake in insulin-dependent diabetic patients with and without autonomic neuropathy. Clin Sci (London), 1997; 93: 325-333.
86. Sisson JC, Wieland DM, Sherman P, Mangner TJ, Tobes MC, Jacques S Jr. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med, 1987; 28: 1620-1624.
87. Stevens MJ, Dayanikli F, Raffel DM et al. Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy. J Am Coll Cardiol, 1998; 31: 1575-1584.
88. Marques JL, George E, Peacey SR et al. Altered ventricular repolarization during hypoglycaemia in patients with diabetes. Diabet Med, 1997; 14: 648-654.
89. Landstedt-Hallin L, Englund A, Adamson U, Lins PE. Increased QT dispersion during hypoglycaemia in patients with type 2 diabetes mellitus. J Intern Med, 1999; 246: 299-307.
90. Robinson RT, Harris ND, Ireland RH, Lee S, Newman C, Heller SR. Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia. Diabetes, 2003; 52: 1469-1474.
91. Tattersall RB, Gill GV. Unexplained deaths of type 1 diabetic patients. Diabet Med, 1991; 8: 49-58.
92. Gill GV, Woodward A, Casson IF, Weston PJ. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes-the "dead in bed" syndrome revisited. Diabetologia, 2009; 52: 42-45.
93. Tu E, Twigg SM, Semsarian C. Sudden death in type 1 diabetes: The mystery of the 'dead in bed' syndrome. Int J Cardiol, 2010; 138: 91-93.
94. Lee SP, Yeoh L, Harris ND et al. Influence of autonomic neuropathy on QTc interval lengthening during hypoglycemia in type 1 diabetes. Diabetes, 2004; 53: 1535-1542.
95. Gerstein HC, Miller ME, Byington RP et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med, 2008; 358: 2545-2559.
96. Tschoepe D, Roesen P, Kaufmann L et al. Evidence for abnormal platelet glycoprotein expression in diabetes mellitus. Eur J Clin Invest, 1990; 20: 166-170.
97. El-Ghoroury EA, El-Din HG, Abdel-Kader M, Ragab S. Study of factor VII, tissue factor pathway inhibitor and monocyte tissue factor in noninsulin-dependent diabetes mellitus. Blood Coagul Fibrinol, 2008; 19: 7-13.
98. Carmassi F, Morale M, Puccetti R et al. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus. Thromb Res, 1992; 67: 643-654.
99. Donders SH, Lustermans FA, van Wersch JW. Glycometabolic control, lipids, and coagulation parameters in patients with non-insulin-dependent diabetes mellitus. Int J Clin Lab Res, 1993; 23: 155-159.
100. Pandolfi A, Cetrullo D, Polishuck R et al. Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects. Arterioscler Thromb Vasc Biol, 2001; 21: 1378-1382.
101. Kario K, Matsuo T, Kobayashi H, Matsuo M, Sakata T, Miyata T. Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria. Arterioscler Thromb Vasc Biol, 1995; 15: 1114-1120.
102. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA, 1979; 241: 2035-2038.
103. Das AK, Das JP, Chandrasekar S. Specific heart muscle disease in diabetes mellitus: A functional structural correlation. Int J Cardiol, 1987; 17: 299-302.
104. Avendano GF, Agarwal RK, Bashey RI et al. Effects of glucose intolerance on myocardial function and collagen-linked glycation. Diabetes, 1999; 48: 1443-1447.
105. Berg TJ, Snorgaard O, Faber J et al. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care, 1999; 22: 1186-1190.
106. Cesario DA, Brar R, Shivkumar K. Alterations in ion channel physiology in diabetic cardiomyopathy. Endocrinol Metab Clin North Am, 2006; 35: 601-610
107. Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care, 2001; 24: 5-10.
108. Redfield MM, Jacobsen SJ, Burnett JC, Jr., Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: Appreciating the scope of the heart failure epidemic. JAMA, 2003; 289: 194-202.
109. Nishimura M, Miyamoto K, Suzuki A et al. Ventilatory and heart rate responses to hypoxia and hypercapnia in patients with diabetes mellitus. Thorax, 1989; 44: 251-257.
110. Sobotka PA, Liss HP, Vinik AI. Impaired hypoxic ventilatory drive in diabetic patients with autonomic neuropathy. J Clin Endocrinol Metab, 1986; 62: 658-663.
111. Williams JG, Morris AI, Hayter RC, Ogilvie CM. Respiratory responses of diabetics to hypoxia, hypercapnia, and exercise. Thorax, 1984; 39: 529-534.
112. Soler NG, Eagleton LE. Autonomic neuropathy and the ventilatory responses of diabetics to progressive hypoxemia and hypercarbia. Diabetes, 1982; 31: 609-614.
113. Calverley PM, Ewing DJ, Campbell IW et al. Preservation of the hypoxic drive to breathing in diabetic autonomic neuropathy. Clin Sci (London), 1982; 63: 17-22.
114. Tantucci C, Scionti L, Bottini P et al. Influence of autonomic neuropathy of different severities on the hypercapnic drive to breathing in diabetic patients. Chest, 1997; 112: 145-153.